Bausch Health Companies Inc (BHC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 341,445 | 313,463 | 235,311 | 221,866 | 215,582 |
| Income taxes - deferred | -37,355 | -191,801 | -107,093 | -5,850 | -14,859 |
| Accounts receivable | -89,227 | -30,182 | -182,646 | 8,183 | -14,786 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | -9,920 |
| Other Working Capital | -105,104 | -37,572 | -114,716 | -31,273 | -69,717 |
| Other Operating Activity | 145,590 | 14,011 | 335,971 | 61,676 | 60,930 |
| Operating Cash Flow | $255,349 | $67,919 | $166,827 | $254,602 | $167,230 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,042 | -102,819 | -57,069 | -13,601 | 55,134 |
| Net Acquisitions | -237,603 | -2,513,087 | -245,367 | -454,020 | -272,812 |
| Purchase Of Investment | 0 | 0 | 0 | 0 | -7,200 |
| Sale Of Investment | 9,027 | 615,362 | 0 | 1,048 | 8,364 |
| Purchase Sale Intangibles | -707 | -64,630 | -6,305 | -695 | -1,865 |
| Other Investing Activity | 8,429 | 91,369 | 11,345 | -8,873 | 0 |
| Investing Cash Flow | $-234,896 | $-1,973,805 | $-297,396 | $-476,141 | $-218,379 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,054 | 2,162 | 4,110 | -9,346 | 7,364 |
| Debt Issued | 0 | 4,597,053 | 122,295 | 640,767 | 645,643 |
| Debt Repayment | -430,036 | -2,074,340 | -93,149 | -127,181 | -306,787 |
| Common Stock Issued | N/A | N/A | 0 | 0 | 5,108 |
| Common Stock Repurchased | -35,005 | 0 | 0 | -172,000 | -108,724 |
| Other Financing Activity | -53,932 | 37,489 | -41,188 | -39,742 | -32,166 |
| Financing Cash Flow | $-515,919 | $2,562,364 | $-7,932 | $292,498 | $210,438 |
| Exchange Rate Effect | -6,889 | 1,883 | 965 | -6,172 | 7,079 |
| Beginning Cash Position | 916,091 | 257,730 | 395,266 | 330,479 | 164,111 |
| End Cash Position | 413,736 | 916,091 | 257,730 | 395,266 | 330,479 |
| Net Cash Flow | $-495,466 | $656,478 | $-138,501 | $70,959 | $159,289 |
| Free Cash Flow | |||||
| Operating Cash Flow | 255,349 | 67,919 | 166,827 | 254,602 | 167,230 |
| Capital Expenditure | -14,749 | -90,482 | -63,374 | -14,296 | -12,981 |
| Free Cash Flow | 240,600 | -22,563 | 103,453 | 240,306 | 154,249 |